“An Analysis of the Benefits of SGLT2 Inhibitors in the Progression of Chronic Kidney Disease Beyond Type 2 Diabetes”. Revista Eletrônica Acervo Médico, vol. 24, Aug. 2024, p. e16309, https://doi.org/10.25248/reamed.e16309.2024.